Dextranomer and Hyaluronate Derivatives (Deflux) and E.S.P.
Determining the interaction of Dextranomer and Hyaluronate Derivatives (Deflux) and E.S.P. and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: Dextranomer and sodium hyaluronate
Generic Name: erythromycin / sulfisoxazole
Brand name:
Synonyms: Erythromycin and sulfisoxazole (Oral), Erythromycin and Sulfisoxazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextranomer and Hyaluronate Derivatives (Deflux)-Easprin
- Dextranomer and Hyaluronate Derivatives (Deflux)-EC-Naprosyn
- Dextranomer and Hyaluronate Derivatives (Deflux)-Echinacea
- Dextranomer and Hyaluronate Derivatives (Deflux)-Echothiophate Iodide
- Dextranomer and Hyaluronate Derivatives (Deflux)-Echothiophate iodide ophthalmic
- Dextranomer and Hyaluronate Derivatives (Deflux)-Econazole
- E.S.P.-Dextranomer and Hyaluronate Derivatives (Solesta)
- E.S.P.-Dextranomer and sodium hyaluronate
- E.S.P.-Dextroamphetamine
- E.S.P.-Dextroamphetamine and amphetamine
- E.S.P.-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- E.S.P.-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)